Rydapt 25 mg, Weichkapseln

7680663100014 CH-66310 Weichkapseln

Associated product:

RYDAPT caps 25 mg 56 pce
Rydapt 25 mg, Weichkapseln
Rydapt 25 mg, Weichkapseln
Rydapt 25 mg, Weichkapseln
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/09/2023
Patient information leaflet
Français
29/09/2023
Patient information leaflet
Italien
29/09/2023
Summary of Product Characteristics
Allemand
29/09/2023
Summary of Product Characteristics
Français
29/09/2023
Summary of Product Characteristics
Italien
29/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
415.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
83.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance ANTON
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66310
Drug name
Rydapt, Weichkapseln
Galenic form
KAPWE
ATC Code
L01EX10
Authorization status
Z
Dispensing category
A
First authorization
04/05/2017
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
akute myeloische Leukämie, systemische Mastozytose

Package details

Description (FR)
RYDAPT caps 25 mg 56 pce
Description (DE)
RYDAPT Kaps 25 mg 56 Stk
Market launch
04/05/2017
Narcotic (BTM)
No

Other package sizes (1)

RYDAPT caps 25 mg 112 pce
112 KAP
GTIN: 7680663100021
View